Shandong Lukang Pharmaceutical Group Saite Co., Ltd, founded in 1999, is the key production base for multi-species Finished Dosage of Lukang, and the High-tech enterprise and Enterprise Technology Center of Shandong Province. Located in No. 518 Lianhuashan road, Xintai City, Shandong Province, Company headquarters is covers an area of 125 mu with the registered capital of 19.81 million yuan. Our main products are tablet, hard capsules, granules, dry suspension agent, dispersing agent, small volume injection, high-capacity injection and the production of API.
Saite stick to science and technology as the guide to develop company, and makes a series of preferential policies for prompting the rapid growth of science and technology personnel. The company has laboratory with first-class facilities for research and development, and the digestion, absorption, development innovation ability, forms a one-stop development system from market research, development and design to trial production and other aspects of new products. The company continuously develops new products for updating products and optimizing the structure.
The company strives for the survival by quality, for the development by credibility, and improves the quality management assurance system. All of workshops have successfully passed the national GMP compliance programs. The company also purchased advanced instruments and equipments for testing to ensure the level of quality testing. The production is conducting in accordance with GMP regulations.
From 2016 to 2020, the company will become a growth production base for multi-species Finished Dosage, promote marketing ability, expand and strengthen solid oral dosage formulations, make injection and infusions to profitability, and supplemented by API, to integrate resource efficiency. By 2020, the company will achieve the main business income of 500 million RMB, the profit of 50 million RMB, the scale of assets reached 390 million RMB.
Company: Shandong Lukang Pharmaceutical Group Saite Co., Ltd.